Validation and Compliance

Oct 01, 2011
BioPharm International
Manufacturers fund research and reduce prices to tackle diseases around the world.
Sep 01, 2011
BioPharm International
Why SOPs are rarely followed, often cited, and in great need of follow-through.
Sep 01, 2011
BioPharm International
PDUFA renewal legislation sets stage for new policies affecting revenue, research, and oversight.
Aug 01, 2011
BioPharm International
Rising imports, overseas production spur collaboration and realignment of enforcement activities.
Aug 01, 2011
BioPharm International
By BioPharm International Editors
US Pharmacopeia promotes horizontal standards and a product-class approach for quality attributes.
Jul 01, 2011
BioPharm International
Follow-on versions of complex biologics require extensive expertise.
Jul 01, 2011
BioPharm International
By BioPharm International Editors
Incorporating regulatory requirements into the product life cycle is crucial.
Jun 01, 2011
BioPharm International
Industry struggles to curb drug abuse, diversion, and disruptions in supply to ensure access to quality products.
May 01, 2011
BioPharm International
FDA, NIH, and industry seek new strategies to spur drug development and promote access to therapies.
May 01, 2011
BioPharm International
By BioPharm International Editors
A rigorous cost-benefit assessment can help to chart a cost-effective path forward.
native1_300x100
lorem ipsum